RxDoctor Payments Data

William Hay, MD

Family Medicine · Brookhaven, MSNPI 1881952489

Payments from drug & device makers

$2,950in general payments, 2019–2025

Across 221 payments — averaging $13.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$646
  • GSK$384
  • Boehringer Ingelheim$383
  • Novo Nordisk$293
  • AbbVie$173
  • Johnson & Johnson$157
  • plus $915 from 17 others

What the payments were for

  • Food & beverage$2,944100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,950 in reported general payments places this provider in the 75th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$83,123
Medicare patients
115
Services billed
841

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban254$65,074
Trelegy ElliptaFluticasone/Umeclidin/Vilanter69$46,559
JardianceEmpagliflozin211$44,536
LinzessLinaclotide43$24,930
OzempicSemaglutide22$22,388
RexultiBrexpiprazole12$18,809
MyrbetriqMirabegron80$17,276
XareltoRivaroxaban63$15,757
Tresiba Flextouch U-200Insulin Degludec15$15,292
GemtesaVibegron50$12,085
DapagliflozinDapagliflozin Propanediol39$10,877
Potassium Chloride484$9,989
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$9,615
JanuviaSitagliptin Phosphate32$9,158
AptiomEslicarbazepine Acetate13$8,619

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat$383$50,251222 claims
GSKTrelegy Ellipta$384$46,55969 claims
AbbVieLinzess$173$24,93043 claims
Novo NordiskOzempic$293$22,38822 claims
Astellas Pharma US IncMyrbetriq$26$17,27680 claims
MerckJanuvia, Janumet Xr$82$16,64258 claims
Johnson & JohnsonXarelto$157$15,75763 claims
AstraZenecaFarxiga, Brilinta$646$12,77782 claims
Sanofi-aventis U.S. LLCLantus$68$4,22339 claims
NovartisEntresto$28$3,13637 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Brookhaven

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →